Get started
Author

Tomoyuki Koga

Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
2017 · Kristen M. Turner, Viraj Deshpande, et al. · Nature · 856
Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
2013 · David A. Nathanson, Beatrice Gini, et al. · Science · 710
NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
2019 · Sudhir Chowdhry, Ciro Zanca, et al. · Nature · 243
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
2019 · Jianhui Ma, Jorge A. Benitez, et al. · Cancer Cell · 164
PDF
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
2021 · Junfeng Bi, Atif Khan, et al. · Cell Reports · 118
PDF
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response
2021 · Jie Li, Megan M. Kaneda, et al. · Proceedings of the National Academy of Sciences · 86
PDF
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
2017 · Ciro Zanca, Genaro R. Villa, et al. · Genes & Development · 74
PDF
Treatment with high marginal dose is mandatory to achieve long-term control of skull base chordomas and chondrosarcomas by means of stereotactic radiosurgery
2010 · Tomoyuki Koga, Masahiro Shin, et al. · Journal of Neuro-Oncology · 66
The long-term outcomes of radiosurgery for arteriovenous malformations in pediatric and adolescent populations
2015 · Shunya Hanakita, Tomoyuki Koga, et al. · Journal of Neurosurgery Pediatrics · 65
PDF
Extended field stereotactic radiosurgery for recurrent glioblastoma
2011 · Tomoyuki Koga, Keisuke Maruyama, et al. · Cancer · 61
The long-term outcomes of radiosurgery for intracranial hemangioblastomas
2013 · S. Hanakita, T. Koga, et al. · Neuro-Oncology · 58
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells
2020 · Tomoyuki Koga, Isaac A. Chaim, et al. · Nature Communications · 57
PDF
Role of Gamma Knife surgery in the treatment of intracranial dural arteriovenous fistulas: Clinical article
2012 · Shunya Hanakita, Tomoyuki Koga, et al. · Journal of neurosurgery · 56
Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation
2009 · Tomoyuki Koga, Akio Morita, et al. · Neuro-Oncology · 53
PDF
Outcomes of Diffusion Tensor Tractography–Integrated Stereotactic Radiosurgery
2011 · Tomoyuki Koga, Keisuke Maruyama, et al. · International Journal of Radiation Oncology*Biology*Physics · 51
Tolerance of Pyramidal Tract to Gamma Knife Radiosurgery Based on Diffusion-Tensor Tractography
2007 · Keisuke Maruyama, Kyousuke Kamada, et al. · International Journal of Radiation Oncology*Biology*Physics · 50
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma
2021 · Jorge A Benitez, Darren Finlay, et al. · Neuro-Oncology · 48
PDF
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
2020 · Alison D. Parisian, Tomoyuki Koga, et al. · Genes & Development · 47
PDF
Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development
2018 · Tomoyuki Koga, Bin Li, et al. · Neuro-Oncology · 41
PDF
Integration of Corticospinal Tractography Reduces Motor Complications After Radiosurgery
2011 · Tomoyuki Koga, Masahiro Shin, et al. · International Journal of Radiation Oncology*Biology*Physics · 40
Stereotactic Radiosurgery for Skull Base Meningioma
2009 · Hiroshi IGAKI, Keisuke MARUYAMA, et al. · Neurologia medico-chirurgica · 40
PDF
Role of Gamma Knife surgery for intracranial atypical (WHO Grade II) meningiomas: Clinical article
2013 · Shunya Hanakita, Tomoyuki Koga, et al. · Journal of neurosurgery · 37
Outcomes of Radiosurgery for Brainstem Arteriovenous Malformations
2011 · Tomoyuki Koga, Masahiro Shin, et al. · Neurosurgery · 37
Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
2022 · Kazuhiko Mishima, Ryo Nishikawa, et al. · Neuro-Oncology · 34
PDF
Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors
2020 · Yuyu He, Jie Li, et al. · Neuro-Oncology · 33
Works count: 97
Citation count: 3,715
H-index: 29
I10-index: 48
Year
Topic
Type